Urology · Longview, TX
NPI
1972570307
Since 2006
Specialty
Urology
Code 208800000X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
802 Medical Dr, Suite 400
Longview, TX, 75605
Phone (903) 757-7871
Groups this clinician bills Medicare through
Medicare paid, 2024
$289K
11,372 services
Medicare patients, 2024
846
Average age 76
Drug cost, 2024
$173K
3,725 prescriptions
Company payments, 2025
$283
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark D Erickstad was code 81003 (clinical chemistry), 1,334 times for 745 patients. In total Mark D Erickstad billed 11,372 services in 85 codes, and Medicare paid $289K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2015-05-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 81003 Clinical Chemistry | Office | 1,334 | 745 | $2.19 | $2,926 |
| 99214 Office E&M - Established | Office | 957 | 556 | $86.55 | $83K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 848 | 570 | $12.10 | $10K |
| 51798 Ultrasound - Nonspecific | Office | 260 | 187 | $7.74 | $2,014 |
| 99213 Office E&M - Established | Office | 234 | 209 | $58.89 | $14K |
| 99212 Office E&M - Established | Office | 216 | 198 | $38.72 | $8,363 |
| 99204 Office E&M - New | Office | 145 | 145 | $111.21 | $16K |
| 36415 Venipuncture Blood Collection | Office | 113 | 102 | $8.65 | $977 |
| 52000 Cystourethroscopy | Office | 109 | 103 | $170.88 | $19K |
| 51741 Test - Miscellaneous | Office | 109 | 84 | $9.89 | $1,077 |
| 99211 Office E&M - Established | Office | 60 | 49 | $17.21 | $1,033 |
| J1580 Injection, garamycin, gentamicin, up to 80 mg | Office | 33 | 33 | $1.95 | $64.38 |
| 55700 Other Organ Systems | Office | 21 | 21 | $175.67 | $3,689 |
| 76942 Ultrasound - Nonspecific | Office | 21 | 21 | $43.76 | $919 |
| 99203 Office E&M - New | Office | 19 | 19 | $68.60 | $1,303 |
By year: 2022 $381K for 32,683 services; 2023 $294K for 32,757 services; 2024 $289K for 11,372 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,334 | 745 | $2.19 | $2,926 |
| 36415 Venipuncture Blood Collection | 113 | 102 | $8.65 | $977 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark D Erickstad prescribed most often to Medicare patients was Tamsulosin Hcl, with 889 prescriptions and refills. In total Mark D Erickstad wrote 3,725 Medicare prescriptions that cost $173K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 889 | 2,008 | 267 | $13K |
| Finasteride Generic | 456 | 1,008 | 113 | $4,758 |
| Doxycycline Monohydrate Generic | 286 | 644 | 104 | $11K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 249 | 449 | 82 | $3,867 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 197 | 251 | 122 | $5,810 |
| Solifenacin Succinate Generic | 176 | 296 | 49 | $4,684 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 146 | 148 | 98 | $2,095 |
| Ciprofloxacin Hcl Generic | 143 | 143 | 116 | $791 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 97 | 97 | 75 | $729 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 82 | 106 | 43 | $716 |
| Levofloxacin Generic | 78 | 78 | 53 | $264 |
| Myrbetriq Mirabegron | 70 | 112 | 17 | $46K |
| Cephalexin Generic | 70 | 78 | 28 | $768 |
| Potassium Citrate Er Potassium Citrate | 68 | 140 | 16 | $7,147 |
| Oxybutynin Chloride Generic | 61 | 139 | 20 | $1,470 |
Brand drugs: - claims; generic drugs: 3,514 claims; opioid claims: 108.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark D Erickstad $283 ($283 in general payments such as food, travel and fees) from 9 companies. The largest payer was Sumitomo Pharma America, Inc. with $80.33.
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. 4506.T | 3 | $80.33 |
| Teleflex LLC TFX | 1 | $33.62 |
| Astellas Pharma US Inc 4503.T | 2 | $33.42 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $31.9 |
| Bioprotect Medical, Inc. | 1 | $26.81 |
| Urogen Pharma, Inc. URGN | 1 | $22.54 |
| Inspire Medical Systems, Inc. INSP | 1 | $19.57 |
| Tolmar, Inc. | 1 | $18.74 |
| Pfizer Inc. PFE | 1 | $16.12 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.